Journal Article Summary
The article investigates how various anti-inflammatory and anti-asthmatic medications affect the activation of platelets by neutrophils, which are a type of white blood cell. This topic is important because understanding how these drugs interact at a cellular level can help improve treatments for conditions where inflammation and blood clotting are involved, such as asthma and other respiratory diseases. The study specifically highlights azelastine, an anti-allergic and anti-asthmatic drug, and its unique ability to inhibit platelet activation.
The researchers tested several drugs, including common anti-inflammatory medications like acetylsalicylic acid and diclofenac, to see how well they could prevent platelet activation induced by neutrophils. They found that azelastine was the only drug that effectively stopped platelet aggregation, with its effects being dose-dependent. While other drugs did not show any significant inhibition, azelastine was able to reduce the release of certain substances from both neutrophils and platelets, although it could be toxic at very high concentrations.
Despite the promising findings regarding azelastine, the study has limitations, including the potential toxicity at high doses, which raises concerns about safety. Patients should be cautious and discuss the implications of these findings with their healthcare providers, especially if they are using azelastine or other anti-inflammatory medications. Understanding these interactions can help in managing treatment plans effectively and ensuring patient safety in conditions involving inflammation and platelet activation.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Renesto P., Balloy V., Vargaftig B. B., Chignard M.. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.. British Journal of Pharmacology 1991. DOI: 10.1111/j.1476-5381.1991.tb09807.x. PMID: 1653073. PMCID: PMC1908358.
Featured Pill Pals Product
Azelastine Nasal Solution One Percent (1%) 30 ml --- Generic For Astelin --- 137 mcg --- 200 Metered Sprays --- Apotex Pharma
Azelastine Nasal Solution One Percent (1%) 30 ml — Generic For Astelin — 137 mcg — 200 Metered Sprays — Apotex Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
